Presently, David Andrew Spence occupies the position of Controller at HLS Therapeutics, Inc. and Vice President & Controller at Nelvana Ltd. Mr. Spence is also Member-Emerging Issues Committee at Canadian Institute of Chartered Accountants.
In the past Mr. Spence was Principal at Sherritt International Corp., Vice President & Controller for Corus Entertainment, Inc. and Principal at PricewaterhouseCoopers LLP.
He received an undergraduate degree from Queen's University.
|